Why BioMarin Pharmaceutical Inc. Stock Is Fading Today
Rare-disease company BioMarin Pharmaceutical (NASDAQ: BMRN) saw its shares plunge by 11.5% right out of the gate Thursday morning. The drugmaker's shares were being pulled down by the markewide sell-off sparked by the global spread of the COVID-19 illness.
Unlike a lot of its biotech peers, however, BioMarin's shares rebounded to some degree as the day's trading progressed. The biotech stock, in fact, was down by 4.72% as of 10:54 a.m. EDT Thursday.
Image source: Getty Images.
Source Fool.com
